Reduction or Discontinuation of TNF-α Inhibitor in Non-infectious Uveitis Patients
NCT05155592
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Uveitis
Adalimumab
Interventions
BIOLOGICAL:
reduction or discontinuation of Adalimumab
Sponsor
Dan Liang